2005 Annual Meeting | Update on MRI: Techniques and Neurologic Applications

Date Saturday 04/16/05

Time 09:00 AM - 12:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Rohit Bakshi, MD, FAAN

Topic(s) Imaging

Learning Objectives Upon completion:
Participants should be able to understand the role of MRI in the management of stroke, multiple sclerosis, spinal diseases, brain tumors, neurodegenerative diseases, and epilepsy; have a basic understanding of how diffusion and perfusion MRI are acquired and the indications for ordering these sequences in a variety of brain disorders, especially ischemia and infarction; explain functional MRI and how it can be used to assess brain metabolisms; and explain MR spectroscopy and how it can be used to study brain lesions.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse, Other

Event Timeline
09:00 AM - 09:30 AM		MRI Technology: The Toolbox Michael Moseley, PhD
09:30 AM - 10:00 AM		MRI of Stroke Michael Moseley, PhD
10:00 AM - 10:30 AM		MRI of Multiple Sclerosis Rohit Bakshi, MD, FAAN
10:30 AM - 10:45 AM		Break
10:45 AM - 11:15 AM		MRI of Spinal Diseases Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN
11:15 AM - 11:45 AM		MRI of Brain Tumors Fred H. Hochberg, MD
11:45 AM - 12:15 PM		MRI of Neurodegenerative Diseases Michael Hutchinson, MD, PhD
12:15 PM - 12:45 PM		MRI of Epilepsy Ruben I. Kuzniecky, MD, FAAN

Faculty Disclosures
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
Michael Moseley, PhD	No disclosure on file
Michael Hutchinson, MD, PhD	No disclosure on file
Fred H. Hochberg, MD	No disclosure on file
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN	Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to AAN interests or activities.
Ruben I. Kuzniecky, MD, FAAN	Dr. Kuzniecky has nothing to disclose.

��ɫ��

��ɫ��